Tetraphase on SPi NewsFollow our SPi News RSS Feed for tetraphase

Featured tetraphase News

[08 Jun 2018] Tetraphase Pharmaceuticals Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

[21 May 2018] Tetraphase Pharmaceuticals to Present Eravacycline and TP-6076 Data at ASM Microbe 2018

[09 May 2018] Tetraphase Pharmaceuticals to Present at the UBS Global Healthcare Conference

[03 May 2018] Tetraphase Pharmaceuticals Reports First Quarter 2018 Financial Results and Recent Highlights

[19 Apr 2018] Tetraphase Pharmaceuticals to Present Data at the 38th Annual Meeting of the Surgical Infection Society

[12 Apr 2018] Tetraphase Pharmaceuticals to Present Data at 28th European Congress of Clinical Microbiology and Infectious Diseases

[02 Apr 2018] Tetraphase Pharmaceuticals to Present at H.C. Wainwright Annual Global Life Sciences Conference

[20 Mar 2018] Tetraphase Pharmaceuticals to Present at 17th Annual Needham Healthcare Conference

[01 Mar 2018] Tetraphase Pharmaceuticals Appoints Larry Edwards Chief Operating Officer

[20 Feb 2018] Tetraphase Pharmaceuticals Enters into Exclusive Development and Commercialization Agreement with Everest Medicines for Eravacycline in China

[02 Jan 2018] Tetraphase Pharmaceuticals Appoints Larry Tsai, M.D. to Chief Medical Officer

[02 Jan 2018] Tetraphase Pharmaceuticals Announces Submission of New Drug Application to FDA for Eravacycline for the Treatment of Complicated Intra-Abdominal Infections (cIAI)

[06 Dec 2017] Tetraphase Pharmaceuticals to Present at BMO Prescriptions for Success in Healthcare Conference 2017

[02 Nov 2017] Tetraphase Pharmaceuticals Reports Third Quarter 2017 Financial Results and Highlights Recent Clinical and Corporate Achievements

[16 Oct 2017] Tetraphase Pharmaceuticals Appoints Kam Unninayar as Chief Financial Officer

[11 Sep 2017] Tetraphase Pharmaceuticals Completes Enrollment of IGNITE3 Phase 3 Clinical Trial of Eravacycline in Complicated Urinary Tract Infections

[17 Aug 2017] Tetraphase Pharmaceuticals Announces Submission and Validation of IV Eravacycline Marketing Authorization Application by European Medicines Agency

[26 Jul 2017] Tetraphase Announces Proposed Public Offering of Common Stock

[17 Jan 2017] Tetraphase Pharmaceuticals Doses First Patient in IGNITE3 Phase 3 Clinical Trial of Once-daily IV Eravacycline in cUTI

[19 Dec 2016] Tetraphase Pharmaceuticals Provides Regulatory and Clinical Update for Eravacycline

[17 Nov 2016] Tetraphase Publishes Phase 3 IGNITE1 Eravacycline Data in JAMA Surgery

[07 Nov 2016] Tetraphase Pharmaceuticals to Present at Stifel 2016 Healthcare Conference

[03 Nov 2016] Tetraphase Pharmaceuticals Reports Third Quarter 2016 Financial Results and Reviews Recent Progress

[26 Oct 2016] Tetraphase Pharmaceuticals Announces Eight Data Presentations at IDWeek 2016

[14 Oct 2016] Tetraphase Pharmaceuticals Doses First Patient in IGNITE4 Phase 3 Clinical Trial of Eravacycline in cIAI

[08 Aug 2016] Tetraphase Pharmaceuticals to Present at 2016 Wedbush PacGrow Healthcare Conference

[04 Aug 2016] Tetraphase Pharmaceuticals Reports Second Quarter 2016 Financial Results and Highlights Recent Progress

[01 Aug 2016] Tetraphase Pharmaceuticals Initiates Phase 1 Clinical Trial for TP-6076, a Second-Generation Antibiotic Candidate Highly Active Against MDR Bacteria

[28 Jun 2016] Tetraphase Pharmaceuticals Added to the Russell Microcap® Index

[20 Jun 2016] Tetraphase Pharmaceuticals Presents Antibiotics Pipeline Data at ASM Microbe 2016

[15 Jun 2016] Tetraphase Pharmaceuticals to Present at 2016 JMP Securities Life Sciences Conference

[23 May 2016] Tetraphase Pharmaceuticals Announces Presentation of Data at ASM Microbe 2016

[12 May 2016] Tetraphase Pharmaceuticals Provides Update on Eravacycline Regulatory and Development Status

[04 May 2016] Tetraphase Pharmaceuticals Reports First Quarter 2016 Financial Results

[07 Apr 2016] Tetraphase Pharmaceuticals to Present Data at 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

[06 Apr 2016] Tetraphase Pharmaceuticals to Present at Needham Conference 2016

[10 Mar 2016] Tetraphase Pharmaceuticals to Present at Roth Conference 2016

[04 Mar 2016] EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. – TTPH

[23 Feb 2016] Tetraphase Pharmaceuticals Reports Fourth-Quarter and Full-Year 2015 Financial Results and Provides Corporate Update

[05 Feb 2016] IMPORTANT TETRAPHASE PHARMACEUTICALS SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Class Action Lawsuit Has Been Commenced Against Tetraphase Pharmaceuticals, Inc. in the District of Massachusetts -- TTPH

[30 Jan 2016] Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Tetraphase Pharmaceuticals Inc. (TTPH)

[19 Jan 2016] Tetraphase Pharmaceuticals Initiates Phase 1 Clinical Trial for TP-271

[25 Aug 2015] Tetraphase Pharmaceuticals to Present Antibiotics Pipeline Data at ICAAC/ICC 2015

[06 Aug 2015] Tetraphase Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference

[05 Aug 2015] Tetraphase Pharmaceuticals Reports Second-Quarter 2015 Financial Results

[29 Jul 2015] Tetraphase to Host Conference Call on August 5th to Discuss Second Quarter 2015 Financial Results

[15 Jul 2015] Tetraphase Pharmaceuticals Announces Appointment of Jacques Dumas, Ph.D. as Chief Scientific Officer

[01 Jul 2015] Tetraphase Pharmaceuticals to Present at Cantor Fitzgerald's Inaugural Healthcare Conference

[17 Dec 2014] The Zacks Analyst Blog Highlights:Pantry, Build-A-Bear Workshop and Tetraphase Pharmaceuticals

[15 Oct 2014] Tetraphase Pharmaceuticals Announces Proposed Public Offering of Common Stock


Still looking?

Type in your search term below and click Enter

World News from SPi

Sector Publishing Intelligence [SPi'] publishes financial news from around the world FAST. For breaking news announcements from companies, blogs and commentators, SPi provides up to the minute, integrated news on all aspects of financial markets and financial services.

The SPi Financial News Search gets results from our extensive news archives containing 10’s of thousands of news reports. Intelligent cross referencing of stories and background gives readers and researchers highly relevant related information about topics and businesses in the finance sector.

Trending financial topics highlight the most recent themes in the news. Thousands of financial topics can be followed using RSS, or join hundreds of SPis Financial News followers on Twitter for instant news as soon as it’s published on SPi. @SPiFinancialSvc

SPi's extensive database of corporate information shows company details alongside breaking corporate news from the world’s largest news providers.

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us